simulatns plus - SLP

SLP

Close Chg Chg %
14.14 0.43 3.04%

Closed Market

14.57

+0.43 (3.04%)

Volume: 272.04K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Company Overview: simulatns plus - SLP

SLP Key Data

Open

$14.25

Day Range

14.03 - 14.71

52 Week Range

12.39 - 37.67

Market Cap

$298.57M

Shares Outstanding

20.15M

Public Float

16.64M

Beta

1.12

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$3.19

Yield

0.00%

Dividend

$0.06

EX-DIVIDEND DATE

Jul 29, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

364.00K

 

SLP Performance

1 Week
 
-13.74%
 
1 Month
 
-25.66%
 
3 Months
 
-14.94%
 
1 Year
 
-59.83%
 
5 Years
 
-82.91%
 

SLP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About simulatns plus - SLP

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

SLP At a Glance

Simulations Plus, Inc.
800 Park Offices Drive
Durham, North Carolina 27709
Phone 1-661-723-7723 Revenue 79.18M
Industry Packaged Software Net Income -64,718,000.00
Sector Technology Services 2025 Sales Growth 13.092%
Fiscal Year-end 08 / 2026 Employees 213
View SEC Filings

SLP Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 3.597
Price to Book Ratio 2.286
Price to Cash Flow Ratio 15.71
Enterprise Value to EBITDA 17.097
Enterprise Value to Sales 3.196
Total Debt to Enterprise Value 0.002

SLP Efficiency

Revenue/Employee 371,732.394
Income Per Employee -303,840.376
Receivables Turnover 5.417
Total Asset Turnover 0.466

SLP Liquidity

Current Ratio 7.665
Quick Ratio 7.665
Cash Ratio 4.811

SLP Profitability

Gross Margin 58.375
Operating Margin 8.325
Pretax Margin -87.62
Net Margin -81.736
Return on Assets -38.117
Return on Equity -42.13
Return on Total Capital -51.602
Return on Invested Capital -42.001

SLP Capital Structure

Total Debt to Total Equity 0.494
Total Debt to Total Capital 0.491
Total Debt to Total Assets 0.467
Long-Term Debt to Equity 0.329
Long-Term Debt to Total Capital 0.327
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Simulatns Plus - SLP

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
53.91M 59.58M 70.01M 79.18M
Sales Growth
+16.01% +10.52% +17.52% +13.09%
Cost of Goods Sold (COGS) incl D&A
10.82M 11.63M 26.86M 32.96M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.57M 3.84M 5.67M 8.21M
Depreciation
300.00K 200.00K 300.00K 300.00K
Amortization of Intangibles
3.27M 3.64M 5.37M 7.91M
COGS Growth
+2.09% +7.47% +130.97% +22.69%
Gross Income
43.08M 47.95M 43.15M 46.22M
Gross Income Growth
+20.12% +11.29% -10.00% +7.11%
Gross Profit Margin
+79.92% +80.48% +61.63% +58.38%
2022 2023 2024 2025 5-year trend
SG&A Expense
28.17M 39.22M 37.02M 39.63M
Research & Development
3.21M 4.50M 5.75M 6.88M
Other SG&A
24.96M 34.72M 31.27M 32.74M
SGA Growth
+14.46% +39.22% -5.61% +7.05%
Other Operating Expense
- - - -
-
Unusual Expense
283.00K 680.00K (1.64M) 76.68M
EBIT after Unusual Expense
14.63M 8.04M 7.77M (70.09M)
Non Operating Income/Expense
487.00K 3.65M 4.64M 712.00K
Non-Operating Interest Income
717.00K 4.13M 4.38M 722.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -100.00%
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
15.12M 11.70M 12.41M (69.38M)
Pretax Income Growth
+36.36% -22.63% +6.12% -659.00%
Pretax Margin
+28.04% +19.63% +17.73% -87.62%
Income Tax
2.63M 1.73M 2.46M (4.66M)
Income Tax - Current - Domestic
3.13M 3.69M 4.03M 688.00K
Income Tax - Current - Foreign
(228.00K) 144.00K 3.00K 108.00K
Income Tax - Deferred - Domestic
(269.00K) (2.10M) (1.58M) (5.46M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
12.48M 9.96M 9.95M (64.72M)
Minority Interest Expense
- - - -
-
Net Income
12.48M 9.96M 9.95M (64.72M)
Net Income Growth
+27.61% -20.20% -0.07% -750.17%
Net Margin Growth
+23.16% +16.72% +14.22% -81.74%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
12.48M 9.96M 9.95M (64.72M)
Preferred Dividends
- - - -
-
Net Income Available to Common
12.48M 9.96M 9.95M (64.72M)
EPS (Basic)
0.6181 0.4962 0.498 -3.2196
EPS (Basic) Growth
+26.66% -19.72% +0.36% -746.51%
Basic Shares Outstanding
20.20M 20.07M 19.99M 20.10M
EPS (Diluted)
0.6016 0.4867 0.4903 -3.2196
EPS (Diluted) Growth
+27.57% -19.10% +0.74% -756.66%
Diluted Shares Outstanding
20.75M 20.46M 20.30M 20.10M
EBITDA
18.48M 12.56M 11.80M 14.80M
EBITDA Growth
+24.54% -32.03% -6.12% +25.49%
EBITDA Margin
+34.29% +21.09% +16.85% +18.70%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 23.333
Number of Ratings 7 Current Quarters Estimate 0.305
FY Report Date 02 / 2026 Current Year's Estimate 1.023
Last Quarter’s Earnings 0.13 Median PE on CY Estimate N/A
Year Ago Earnings 1.03 Next Fiscal Year Estimate 1.065
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 7 6
Mean Estimate 0.31 0.32 1.02 1.07
High Estimates 0.33 0.36 1.09 1.15
Low Estimate 0.23 0.27 0.92 0.95
Coefficient of Variance 12.40 11.35 4.98 7.62

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 4
OVERWEIGHT 0 0 0
HOLD 4 4 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Simulatns Plus in the News